BioSpace News Archive

Business

Biotec Pharmacon Q1 2019 Results

Biotec Pharmacon (OSE: Biotec) announces its Q1 2019 results to 31 March 2019.

May 1, 2019
·
3 min read
Sequana Medical announces acceptance of late-breaking abstract of DSR therapy for volume overload in heart failure at Heart Failure 2019 Congress

Sequana Medical NV (Euronext Brussels: SEQUA), today announces that results from the first-in-human single dose DSR (Direct Sodium Removal) proof-of-concept study for volume overload in heart failure have been selected for oral presentation in the late-breaking abstract session at Heart Failure 2019 on 27 May 2019

May 1, 2019
·
7 min read
Biotech Beach

New ‘POWERMOM’ app launched to study maternal health

In the United States, spending on hospital-based maternity care surpasses that of any other country, yet rates of maternal morbidity and mortality are rising, despite declines elsewhere.

May 1, 2019
·
3 min read
In the United States, spending on hospital-based maternity care surpasses that of any other country, yet rates of maternal morbidity and mortality are rising, despite declines elsewhere.

The MagMAX Viral/Pathogen Nucleic Acid Isolation Kit is a new automation-ready kit for scalable recovery of RNA and DNA from viral particles and gram-negative bacteria.

May 1, 2019
·
1 min read
Deals

Community Healthcare Trust Incorporated Announces Increased First Quarter Dividend - May 1, 2019

Community Healthcare Trust Incorporated announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2019.

May 1, 2019
·
3 min read
Business

Nektar to Announce Financial Results for the First Quarter 2019 on Wednesday, May 8, 2019, After Close of U.S.-Based Financial Markets

Howard Robin, President and Chief Executive Officer, will host a conference call to review the results beginning at 5:00 p.m. Eastern Daylight Time/2:00 p.m. Pacific Daylight Time.

May 1, 2019
·
1 min read
Drug Development

Celgene Corporation and bluebird bio Announce Results from Ongoing Multicenter Phase 1 Study of bb2121 anti-BCMA CAR T Cell Therapy in Patients with Multiple Myeloma Published in New England Journal of Medicine

The manuscript, “Anti-BCMA CAR T Cell Therapy bb2121 in Relapsed/Refractory Multiple Myeloma”, published in NEJM includes key safety and efficacy results from the dose escalation and first expansion cohort, including a minimum of six months follow up on all subjects.

May 1, 2019
·
10 min read
Securing Endografts for Abdominal Aortic Aneurysms with Flexible Shaft Technology

A new endovascular aneurysm repair device features S.S. White expertise

May 1, 2019
·
6 min read
Pharm Country

Skyrocketing Pharmaceutical Prices Are Putting Pressure on Healthcare Industry, According to TD Bank Survey

Participants were surveyed at the Becker’s Hospital Review 10th Annual Meeting.

May 1, 2019
·
4 min read
Business

Myriad Announces Coverage Decision by Kroger® Prescription Plans for GeneSight®

Agreement Also Includes In-store Interventions at Kroger Pharmacies Nationwide

May 1, 2019
·
7 min read